Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Oncorus, Inc. (ONCR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
28 Dec 2022
Flynn James E
10% Owner, Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,156,309
-22%
336,235
$0.26
$88,253.72
SELL
22 Dec 2022
Flynn James E
10% Owner, Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,305,999
-5%
73,384
$0.27
$19,896.62
SELL
19 Dec 2022
Flynn James E
10% Owner, *Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,338,668
-8%
128,258
$0.29
$37,627.62
SELL
13 Dec 2022
Flynn James E
10% Owner, *Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,395,768
-0%
13,786
$0.39
$5,332.48
BUY
25 May 2022
Wanstall Rick
CFO and Treasurer, Officer
Oncorus, Inc.
(ONCR)
51,000
+7%
3,777
$1.20
$4,532.40
BUY
20 May 2022
Wanstall Rick
CFO and Treasurer, Officer
Oncorus, Inc.
(ONCR)
47,223
+3%
1,610
$1.20
$1,932.00
BUY
17 May 2022
Wanstall Rick
CFO and Treasurer, Officer
Oncorus, Inc.
(ONCR)
45,613
+12%
5,001
$1.29
$6,451.20
BUY
12 May 2022
Wanstall Rick
CFO and Treasurer, Officer
Oncorus, Inc.
(ONCR)
40,612
+1930%
38,612
$1.14
$44,035.82
BUY
16 Nov 2021
Harbin Stephen
COO and Chief of Staff, Officer
Oncorus, Inc.
(ONCR)
15,000
+200%
30,000
$5.79
$173,655.00
SELL
1 Jun 2021
Queva Christophe
CSO and SVP, Research, Officer
Oncorus, Inc.
(ONCR)
47,626
-33%
23,555
$16.68
$392,813.25
SELL
30 Apr 2021
Queva Christophe
CSO and SVP, Research, Officer
Oncorus, Inc.
(ONCR)
36,420
-39%
23,555
$15.97
$376,122.70
SELL
26 Apr 2021
Queva Christophe
CSO and SVP, Research, Officer
Oncorus, Inc.
(ONCR)
59,175
-23%
18,255
$15.22
$277,782.80
SELL
6 Apr 2021
Queva Christophe
CSO and SVP, Research, Officer
Oncorus, Inc.
(ONCR)
77,430
-6%
5,300
$15.01
$79,553.00
BUY
17 Feb 2021
Flynn James E
Director, 10% Owner, *Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,401,905
+27%
300,000
$19.00
$5,700,000.00
BUY
6 Oct 2020
MPM BioVentures 2014, L.P.
10% Owner
Oncorus, Inc.
(ONCR)
2,849,453
+6%
173,776
$15.00
$2,606,640.00
BUY
6 Oct 2020
UBS Oncology Impact Fund L.P.
10% Owner
Oncorus, Inc.
(ONCR)
2,377,025
+6%
151,224
$15.00
$2,268,360.00
BUY
6 Oct 2020
EVNIN LUKE
Director, 10% Owner
Oncorus, Inc.
(ONCR)
2,492,843
+6%
151,225
$15.00
$2,268,375.00
BUY
6 Oct 2020
Flynn James E
Director, 10% Owner, *Possible Member of 10% Group
Oncorus, Inc.
(ONCR)
1,268,344
+372%
1,000,000
$15.00
$15,000,000.00
BUY
6 Oct 2020
MPM SunStates Fund, L.P.
10% Owner
Oncorus, Inc.
(ONCR)
2,849,453
+6%
173,776
$15.00
$2,606,640.00
BUY
6 Oct 2020
GADICKE ANSBERT
10% Owner
Oncorus, Inc.
(ONCR)
2,849,453
+12%
325,000
$15.00
$4,875,000.00
Home